Kairos Pharma, Ltd. (KAPA)
NYSE American · Manufacturing · Pharmaceutical preparations
$1.75−$0.0236 (−1.33%) on the dayAs of the close; data may be delayed.
KAPA price, last 12 months
Key stats
- Previous close
- $1.77
- Open
- $1.72
- Day range
- $1.72 – $1.80
- 52-week range
- $1.51 – $9.59
- Volume
- 40.8K
- Avg volume (20 days)
- 101.2K
- Market cap
- $5.8M
Performance
1W+1.0%
1M−4.0%
3M−28.7%
6M−57.6%
YTD−64.9%
1Y−79.2%
vs S&P 500, 1Y−96.0 pts
Technicals and fundamentals
About Kairos Pharma, Ltd.
Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. The company is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The product portfolio of the company consists of Pre-clinical or clinical-trial stage drug candidates, Therapeutic agents, and other technologies for treating diseases.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NYSE American
- Market cap
- $5.8M